Profound Medical Corp
TSX:PRN
Profound Medical Corp
Operating Income
Profound Medical Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
Operating Income
-$33.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Titan Medical Inc
TSX:TMD
|
Operating Income
-$2.3m
|
CAGR 3-Years
48%
|
CAGR 5-Years
49%
|
CAGR 10-Years
14%
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Operating Income
-CA$13.5m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Operating Income
-CA$4.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-5%
|
|
|
MedMira Inc
XTSX:MIR
|
Operating Income
-CA$2.9m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
1%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Operating Income
-CA$14.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
See Also
What is Profound Medical Corp's Operating Income?
Operating Income
-33.1m
USD
Based on the financial report for Dec 31, 2024, Profound Medical Corp's Operating Income amounts to -33.1m USD.
What is Profound Medical Corp's Operating Income growth rate?
Operating Income CAGR 5Y
-17%
Over the last year, the Operating Income growth was -16%. The average annual Operating Income growth rates for Profound Medical Corp have been -3% over the past three years , -17% over the past five years .
You don't have any saved screeners yet